Guangsheng Zhu

Key Laboratory Of Digestive Cancer Of Tianjin
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

P2RY13-Negative Tumor-Associated Macrophages Promote NETosis and Are Associated with Poor Prognosis Across Multiple Cancers.

P2RY13-Negative Tumor-Associated Macrophages Promote NETosis and Are Associated with Poor Prognosis Across Multiple Cancers.

Journal: Cancers

Published: June 03, 2026

Acid-modified biochar drive U(VI) bioreduction via leachable persistent free radicals: Mechanisms of extracellular electron transfer and microbial synergy.

Acid-modified biochar drive U(VI) bioreduction via leachable persistent free radicals: Mechanisms of extracellular electron transfer and microbial synergy.

Journal: Journal of hazardous materials

Published: May 07, 2025

CD40LG Downregulation in Lung Adenocarcinoma: A Prognostic Biomarker Linked to Immune Cell Infiltration and Survival Outcomes.

CD40LG Downregulation in Lung Adenocarcinoma: A Prognostic Biomarker Linked to Immune Cell Infiltration and Survival Outcomes.

Journal: Journal of Cancer

Published: April 10, 2025

Corrigendum: ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.

Corrigendum: ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.

Journal: Frontiers in immunology

Published: April 11, 2024

Myofibroblasts derived type V collagen promoting tissue mechanical stress and facilitating metastasis and therapy resistance of lung adenocarcinoma cells.

Myofibroblasts derived type V collagen promoting tissue mechanical stress and facilitating metastasis and therapy resistance of lung adenocarcinoma cells.

Journal: Cell death & disease

Published: March 04, 2024

ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.

ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.

Journal: Frontiers in immunology

Published: February 05, 2024

Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker  for Lung Adenocarcinoma

Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker  for Lung Adenocarcinoma

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: January 31, 2024

Pan-cancer analysis combined with experiments predicts NNMT as a therapeutic target for human cancers.

Pan-cancer analysis combined with experiments predicts NNMT as a therapeutic target for human cancers.

Journal: Discover oncology

Published: November 11, 2023

ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.

ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.

Journal: Journal of Cancer

Published: November 06, 2023

Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.

Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.

Journal: Frontiers in immunology

Published: September 29, 2023

Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population.

Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population.

Journal: OncoTargets and therapy

Published: May 04, 2023

L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma.

L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma.

Journal: Cell death & disease

Published: April 10, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026